Earnings Feed
Sign Up
Home/Filings/4/0001662252-17-000207
4//SEC Filing

Callaway James Eric 4

Accession 0001662252-17-000207

CIK 0001534525other
View on SEC.govCompany Profile

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 4:54 PM ET

Size

12.3 KB

Accession

0001662252-17-000207

Insider Transaction Report

Form 4
Period: 2017-10-11
Xenetic Biosciences, Inc.XBIO
Callaway James Eric
Director
Transactions
  • Award

    Stock Option

    2017-10-11+6,250→ 12,500 total
    Exercise: $2.95From: 2018-04-11Exp: 2027-10-11→ Common Stock (6,250 underlying)
  • Award

    Stock Option

    2017-10-11+6,250→ 18,750 total
    Exercise: $2.95From: 2018-07-11Exp: 2027-10-11→ Common Stock (6,250 underlying)
  • Award

    Stock Option

    2017-10-11+6,250→ 25,000 total
    Exercise: $2.95From: 2018-10-11Exp: 2027-10-11→ Common Stock (6,250 underlying)
  • Award

    Stock Option

    2017-10-11+6,250→ 6,250 total
    Exercise: $2.95From: 2018-01-11Exp: 2027-10-11→ Common Stock (6,250 underlying)
Footnotes (1)
  • [F1]On October 11, 2017 the Issuer approved the issuance of a Stock Option Grant to the Reporting Owner under its 2014 Equity Incentive Plan (the "Plan"). The Reporting Owner has the right to purchase 25,000 shares of common stock of the Issuer under the Plan at an exercise price based on the closing price on October 11, 2017 of $2.95. The Option vests one-quarter of the total grant for each quarter of service over the twelve-month period commencing on the grant date.

Documents

1 file

Issuer

Xenetic Biosciences, Inc.

CIK 0001534525

→
Entity typeother

Related Parties

1
  • filerCIK 0001715787

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:54 PM ET
Size
12.3 KB
View on SEC.gov